Francesco Parmeggiani

Summary

Affiliation: University of Ferrara
Country: Italy

Publications

  1. Parmeggiani F, Romano M, Costagliola C, Semeraro F, Incorvaia C, D Angelo S, et al. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012;2012:546786 pubmed publisher
    ....
  2. request reprint
    Parmeggiani F, Costagliola C, Gemmati D, D Angelo S, Perri P, Scapoli G, et al. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration. Pharmacogenet Genomics. 2007;17:1039-46 pubmed
    ..36), P<0.001]. These results provide evidences for the presence of pharmacogenetic relationship between peculiar coagulation-balance gene polymorphisms and different levels of PDT-V effectiveness in patients with AMD-related CNV. ..
  3. Parmeggiani F, Costagliola C, Gemmati D, D Angelo S, Perri P, Campa C, et al. Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:3100-6 pubmed publisher
    ..These data provide evidence of the presence of a pharmacogenetic relationship between peculiar coagulation-balance genetic backgrounds and different levels of PDT-V effectiveness in patients with AMD with occult CNV. ..
  4. Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, D Angelo S, Perri P, et al. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia. Ophthalmology. 2010;117:517-23 pubmed publisher
    ..These findings document the presence of pharmacogenetic correlations between common coagulation-balance gene polymorphisms and different CNV responsiveness to PDT-V in Caucasian patients with neovascular PM. ..

Locale

Detail Information

Publications4

  1. Parmeggiani F, Romano M, Costagliola C, Semeraro F, Incorvaia C, D Angelo S, et al. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012;2012:546786 pubmed publisher
    ....
  2. request reprint
    Parmeggiani F, Costagliola C, Gemmati D, D Angelo S, Perri P, Scapoli G, et al. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration. Pharmacogenet Genomics. 2007;17:1039-46 pubmed
    ..36), P<0.001]. These results provide evidences for the presence of pharmacogenetic relationship between peculiar coagulation-balance gene polymorphisms and different levels of PDT-V effectiveness in patients with AMD-related CNV. ..
  3. Parmeggiani F, Costagliola C, Gemmati D, D Angelo S, Perri P, Campa C, et al. Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:3100-6 pubmed publisher
    ..These data provide evidence of the presence of a pharmacogenetic relationship between peculiar coagulation-balance genetic backgrounds and different levels of PDT-V effectiveness in patients with AMD with occult CNV. ..
  4. Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, D Angelo S, Perri P, et al. Impact of coagulation-balance gene predictors on efficacy of photodynamic therapy for choroidal neovascularization in pathologic myopia. Ophthalmology. 2010;117:517-23 pubmed publisher
    ..These findings document the presence of pharmacogenetic correlations between common coagulation-balance gene polymorphisms and different CNV responsiveness to PDT-V in Caucasian patients with neovascular PM. ..